Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02176824 · ClinicalTrials.gov registry record · NA
Chronotherapy Randomized Controlled Trial
A NA study, sponsored by Medical University of South Carolina.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT02176824: Clinical Trial NA study, sponsored by Medical University of South Carolina.
NCT02176824 is a NA study that was terminated before completion, run by Medical University of South Carolina. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02176824, a NA study, was terminated before completion, sponsored by Medical University of South Carolina.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
Chronotherapy is a term that describes therapeutic alterations of sleep wake cycles. Different variations of sleep deprivation, set sleep wake schedules, and types of light therapy have demonstrated efficacy in rapidly treating depression, and suicidal thinking. This study seeks to explore the effect of two different chronotherapuetic protocols on acutely depressed and suicidal inpatients admitted to the Medical University of South Carolina
Primary Outcome
Change in scores from Pre and Post Hamilton Depression scores
Interventions
- OTHER Treatment as usual
- BEHAVIORAL Total Sleep deprivation, Sleep Phase Advance, and Bright Light Therapy
- BEHAVIORAL Partial Sleep deprivation, Sleep Phase Delay, and Low amber light.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2014-06-01 |
| Est. Completion | 2016-04-07 |
| Phase | NA |
Why NCT02176824 stopped before completion
NCT02176824 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Treatment as usual is the first listed.
NCT02176824 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02176824 about?
NCT02176824 is a clinical study titled "Chronotherapy Randomized Controlled Trial". Chronotherapy is a term that describes therapeutic alterations of sleep wake cycles. Different variations of sleep deprivation, set sleep wake schedules, and types of light therapy have demonstrated efficacy in rapidly treating depression, and suicidal thinking. This study seeks to explore the effec...
What is the current status of trial NCT02176824?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2014-06-01. Estimated completion is 2016-04-07.
What interventions are being tested in trial NCT02176824?
The interventions under investigation include: Treatment as usual (OTHER), Total Sleep deprivation, Sleep Phase Advance, and Bright Light Therapy (BEHAVIORAL), Partial Sleep deprivation, Sleep Phase Delay, and Low amber light. (BEHAVIORAL).
Who is sponsoring clinical trial NCT02176824?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02176824's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI